M
GLUE//CIK 0001826457
Monte Rosa Therapeutics, Inc.
Market Data
$15.83+$2.05 (+14.88%)
GLUE · Last trade
Prev Close
$13.78
Range (29d)
$13.52 – $18.66
Recent Filings
- 8-K12.2 MBMonte Rosa Therapeutics, Inc.Dec 16, 7:30 AM ET·0001193125-25-319981
- 8-K172.0 KBMonte Rosa Therapeutics, Inc.Dec 13, 7:03 AM ET·0000950170-24-136042
- 8-K37.6 MBMonte Rosa Therapeutics, Inc.Dec 5, 7:03 AM ET·0000950170-24-133525
- SC 13G/A7.2 KBMonte Rosa Therapeutics, Inc.Nov 14, 1:22 PM ET·0000080255-24-001467
- SC 13G/A8.2 KBMonte Rosa Therapeutics, Inc.Nov 12, 10:32 AM ET·0000315066-24-002827
- 10-Q8.0 MBMonte Rosa Therapeutics, Inc.Nov 7, 7:07 AM ET·0000950170-24-122780
- 8-K468.3 KBMonte Rosa Therapeutics, Inc.Nov 7, 7:02 AM ET·0000950170-24-122766
- SC 13D/A113.4 KBMonte Rosa Therapeutics, Inc.Oct 30, 5:10 PM ET·0001193125-24-247656
- 8-K225.4 KBMonte Rosa Therapeutics, Inc.Oct 28, 6:59 AM ET·0000950170-24-117567
- SC 13D/A112.4 KBMonte Rosa Therapeutics, Inc.Sep 24, 5:00 PM ET·0001193125-24-224875
Insiders
10- Behbahani AliDirector, 10% Owner
- Blackwell KimberlyDirector
- Bolzon Bradley J PhDDirector, 10% Owner
- Champoux JenniferChief Operating Officer
- Dunn EdmundPrincipal Accounting Officer
- Hughes Eric ADirector
- Janku FilipChief Medical Officer
- Jones Jullian GChief Business Officer
- Leo Chandra P.Director
- Manning Anthony M.Director
Tickers
Addresses
business
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
mailing
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
Former Names
- Monte Rosa Therapeutics, Inc.2025-12-16